#ADC_Development

Thiard News@F4F

@newsen.bsky.social

2 days ago

BioDlink Earns Title of 'Emerging CDMO of the Year' at Asia-Pacific Biopharma Awards BioDlink has been awarded 'Emerging CDMO of the Year,' recognizing its innovation in biologics and ADC development through advanced technology and quality systems.

BioDlink Earns Title of 'Emerging CDMO of the Year' at Asia-Pacific Biopharma Awards #China #Suzhou #biopharmaceuticals #ADC_Development #BioDlink

Thiard News@F4F

@newsen.bsky.social

4 months ago

Mycenax Biotech Partners with RIN Institute to Advance ADC Development with Innovative Linker Technology Mycenax Biotech has signed a licensing agreement with RIN Institute to utilize its proprietary linker technology. This partnership aims to accelerate ADC development and offers enhanced therapeutic solutions.

Mycenax Biotech Partners with RIN Institute to Advance ADC Development with Innovative Linker Technology #Taiwan #Taipei #ADC_Development #Mycenax_Biotech #RIN_Institute

Thiard News@F4F

@newsen.bsky.social

4 months ago

Mycenax Biotech Partners with RIN to Enhance ADC Development Using Advanced Linker Technology Mycenax Biotech Inc. and Japan's RIN Institute team up through a license agreement to utilize innovative linker technology for developing advanced ADCs.

Mycenax Biotech Partners with RIN to Enhance ADC Development Using Advanced Linker Technology #Taiwan #Taipei #ADC_Development #Mycenax_Biotech #RIN_Institute

Thiard News@F4F

@newsen.bsky.social

4 months ago

Piramal Pharma and IntoCell Join Forces to Enhance Bioconjugate Platforms and Capabilities Piramal Pharma Solutions has announced a strategic partnership with IntoCell to expand its bioconjugate capabilities, leveraging innovative payload-linker technologies.

Piramal Pharma and IntoCell Join Forces to Enhance Bioconjugate Platforms and Capabilities #India #Mumbai #ADC_Development #Piramal_Pharma #IntoCell

Thiard News@F4F

@newsen.bsky.social

4 months ago

Piramal Pharma Solutions Partners with IntoCell for Enhanced Bioconjugate Technology Piramal Pharma Solutions has established a partnership with IntoCell to enhance its bioconjugate capabilities and expedite drug development efforts.

Piramal Pharma Solutions Partners with IntoCell for Enhanced Bioconjugate Technology #India #Mumbai #ADC_Development #Piramal_Pharma_Solutions #IntoCell

Thiard News@F4F

@newsen.bsky.social

4 months ago

Syngene International Expands Bioconjugation Suite for ADC Development Expertise Syngene International is set to enhance its services with a new GMP bioconjugation suite, facilitating end-to-end antibody-drug conjugate development. This expansion will streamline drug development processes for biotech clients.

Syngene International Expands Bioconjugation Suite for ADC Development Expertise #India #Bengaluru #Bioconjugation #ADC_Development #Syngene_International

Thiard News@F4F

@newsen.bsky.social

6 months ago

Mycenax Biotech and SPERA PHARMA Forge Strategic Alliance for ADC Development Mycenax Biotech Inc. and SPERA PHARMA Inc. have joined forces to enhance the production services of antibody-drug conjugates, streamlining development for biopharmaceutical companies.

Mycenax Biotech and SPERA PHARMA Forge Strategic Alliance for ADC Development #Taiwan #Taipei #ADC_Development #SPERA_PHARMA #Mycenax_Biotech

Thiard News@F4F

@newsen.bsky.social

1 year ago

WuXi XDC and LigaChem Optimize ADC Development through Expanded Partnership WuXi XDC and LigaChem Biosciences have enhanced their collaboration with a new MOU to accelerate the development of next-gen ADC therapies, improving treatment options for cancer patients.

WuXi XDC and LigaChem Optimize ADC Development through Expanded Partnership #China #Shanghai #ADC_Development #WuXi_XDC #LigaChem

Thiard News@F4F

@newsen.bsky.social

1 year ago

DAAN Biotherapeutics Partners with LigaChem for Advanced ADC Development DAAN Biotherapeutics has signed an exclusive licensing agreement with LigaChem Biosciences to enhance antibody-drug conjugate (ADC) therapeutic development.

DAAN Biotherapeutics Partners with LigaChem for Advanced ADC Development #South_Korea #Seoul #LigaChem_Biosciences #ADC_Development #DAAN_Biotherapeutics

Thiard News@F4F

@newsen.bsky.social

1 year ago

Samsung Biologics Enhances ADC Development with LigaChem Biosciences Collaboration Samsung Biologics announces the extension of its collaboration with LigaChem Biosciences to enhance antibody-drug conjugate (ADC) development services.

Samsung Biologics Enhances ADC Development with LigaChem Biosciences Collaboration #South_Korea #Samsung_Biologics #Incheon #LigaChem_Biosciences #ADC_Development